Darwin Global Management as of Sept. 30, 2021
Portfolio Holdings for Darwin Global Management
Darwin Global Management holds 12 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Acceleron Pharma | 63.4 | $344M | 2.0M | 172.10 | |
| Intellia Therapeutics (NTLA) | 18.6 | $101M | 752k | 134.15 | |
| Biontech Se Sponsored Ads (BNTX) | 6.7 | $36M | 133k | 272.99 | |
| Fate Therapeutics (FATE) | 3.9 | $21M | 353k | 59.27 | |
| Inhibrx | 3.3 | $18M | 543k | 33.31 | |
| Bridgebio Pharma (BBIO) | 2.2 | $12M | 254k | 46.87 | |
| Adagio Therapeutics (IVVD) | 0.7 | $3.7M | 87k | 42.24 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $2.9M | 159k | 18.00 | |
| Vir Biotechnology (VIR) | 0.4 | $2.0M | 45k | 43.52 | |
| Verve Therapeutics (VERV) | 0.2 | $1.3M | 27k | 47.01 | |
| Fulcrum Therapeutics (FULC) | 0.2 | $959k | 34k | 28.21 | |
| Aerovate Therapeutics (AVTE) | 0.0 | $262k | 13k | 20.99 |
